A Study of Bemcentinib for the Treatment of COVID-19 in Hospitalised Patients
Clinical trial NCT04890509 · COMPLETED
Trial details
- NCT number
- NCT04890509
- Sponsor
- BerGenBio ASA
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-20
- Primary completion
- 2021-05-25
- Enrollment
- 115
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.